The purpose of this SOP is to describe the procedures for applying for and maintaining a Clinical Trial Authorisation for Trials sponsored or co-sponsored by King‟s Health Partner Organisations in order to comply with UK Regulations and European Law.
The CTA submission package will be prepared and submitted by the KHP CTO CRA with collaboration from King's Health Partner Pharmacy Departments and the Chief Investigator Team as required.
SOP:Application and Maintenance of a CTA v8 (350KB)
REC Annual Progress Report Process Map(.ppt, 125Kb)
KHPCTO amendment assessment form v6(.doc 892Kb)
